Blood-testing startup Theranos Inc. will fire about 41 percent of its employees after months of regulatory setbacks, lawsuits and scrutiny, saying it is paring down to focus on a new product.
The Silicon Valley company will eliminate 155 positions, leaving 220 employees who will work on the new product, a tabletop blood testing product called the miniLab.
